AION Labs: innovation lab launch
Aion Labs, an innovation lab aimed at driving adoption of artificial intelligence and computational science to solve therapeutic challenges, has announced its official launch and opening of its Israel headquarters. It comes out of an alliance among pharma giants AstraZeneca, Merck, Pfizer, and Teva; and tech/biotech leaders Amazon Web Services and Israel Biotech Fund.
Mati Gill, Aion Labs CEO, said, “Our R&D needs-based approach, coupled with our outstanding alliance, is poised to transform the process of therapeutic discovery and development. With a strong talent pool, AI technology at our core and a significant commitment of the Israeli government, we hope to contribute to the health and well-being of humankind.”
